Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients.

Masson Regnault, M; Konstantinou, M-P; Khemis, A; Poulin, Y; Bourcier, M; Amelot, F; Bulaï Livideanu, C; Paul, C

Masson Regnault, M; Konstantinou, M-P; Khemis, A; Poulin, Y; Bourcier, M; Amelot, F; Bulaï Livideanu, C; Paul, C.

Afiliação

Masson Regnault M; Department of Dermatology, Larrey Hospital and Toulouse University, Toulouse, France.
Konstantinou MP; Department of Dermatology, Larrey Hospital and Toulouse University, Toulouse, France.
Khemis A; Department of Dermatology, University Hospital of Nice, Nice, France.
Poulin Y; Department of Dermatology, Metropolitan Quebec, Quebec, QC, Canada.
Bourcier M; Department of Dermatology, Hop G. L, Moncton, NB, Canada.
Amelot F; Department of Dermatology, Larrey Hospital and Toulouse University, Toulouse, France.
Bulaï Livideanu C; Department of Dermatology, Larrey Hospital and Toulouse University, Toulouse, France.
Paul C; Department of Dermatology, Larrey Hospital and Toulouse University, Toulouse, France.

J Eur Acad Dermatol Venereol ; 31(9): 1491-1496, 2017 Sep.

Article em En | MEDLINE | ID: mdl-28585707

Assuntos

Anticorpos Monoclonais/uso terapêutico; Fármacos Dermatológicos/uso terapêutico; Psoríase/patologia; Adulto; Idoso; Anticorpos Monoclonais Humanizados; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Psoríase/tratamento farmacológico; Recidiva; Estudos Retrospectivos; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google